Stephen Yanofsky

1.1k total citations
17 papers, 873 citations indexed

About

Stephen Yanofsky is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Stephen Yanofsky has authored 17 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Genetics. Recurrent topics in Stephen Yanofsky's work include Immune Response and Inflammation (5 papers), Bacterial Genetics and Biotechnology (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Stephen Yanofsky is often cited by papers focused on Immune Response and Inflammation (5 papers), Bacterial Genetics and Biotechnology (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Stephen Yanofsky collaborates with scholars based in United States. Stephen Yanofsky's co-authors include Ronald W. Barrett, Terry L. Bowlin, Junetsu Ito, Fujio Kawamura, Ann L. Akeson, Edoardo Sarubbi, Chantal Tardif, Adolfo Soffientini, Herman Schreuder and H W Boyer and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Stephen Yanofsky

17 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Yanofsky United States 15 559 235 212 138 121 17 873
Edward G. Bernstine United States 9 754 1.3× 92 0.4× 242 1.1× 81 0.6× 18 0.1× 11 959
Guang‐Jer Wu United States 23 865 1.5× 109 0.5× 206 1.0× 81 0.6× 70 0.6× 48 1.3k
S.M. Rybak United States 19 830 1.5× 417 1.8× 117 0.6× 272 2.0× 67 0.6× 29 1.2k
Dorothy Yuan United States 19 413 0.7× 568 2.4× 184 0.9× 126 0.9× 72 0.6× 38 1.0k
Dominique Semon Switzerland 8 408 0.7× 195 0.8× 170 0.8× 68 0.5× 62 0.5× 8 694
Stuart Weisbrod United States 7 1.2k 2.1× 95 0.4× 248 1.2× 40 0.3× 30 0.2× 7 1.3k
K M Lo United States 9 724 1.3× 230 1.0× 133 0.6× 34 0.2× 20 0.2× 10 1.1k
George L. Eliceiri United States 21 1.6k 2.8× 89 0.4× 206 1.0× 73 0.5× 37 0.3× 66 1.9k
Hans Türler Switzerland 15 452 0.8× 163 0.7× 104 0.5× 76 0.6× 94 0.8× 35 872
A R Goldberg United States 13 548 1.0× 61 0.3× 149 0.7× 124 0.9× 42 0.3× 16 797

Countries citing papers authored by Stephen Yanofsky

Since Specialization
Citations

This map shows the geographic impact of Stephen Yanofsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Yanofsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Yanofsky more than expected).

Fields of papers citing papers by Stephen Yanofsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Yanofsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Yanofsky. The network helps show where Stephen Yanofsky may publish in the future.

Co-authorship network of co-authors of Stephen Yanofsky

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Yanofsky. A scholar is included among the top collaborators of Stephen Yanofsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Yanofsky. Stephen Yanofsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Arey, Brian J., Stephen Yanofsky, M. Pérez, et al.. (2008). Differing pharmacological activities of thiazolidinone analogs at the FSH receptor. Biochemical and Biophysical Research Communications. 368(3). 723–728. 47 indexed citations
2.
Yanofsky, Stephen, Emily S. Shen, Erik A. Whitehorn, et al.. (2006). Allosteric Activation of the Follicle-stimulating Hormone (FSH) Receptor by Selective, Nonpeptide Agonists. Journal of Biological Chemistry. 281(19). 13226–13233. 70 indexed citations
3.
Maclean, Derek, Ann M. Davis, Stephen Yanofsky, et al.. (2003). Agonists of the Follicle Stimulating Hormone Receptor from an Encoded Thiazolidinone Library. Journal of Combinatorial Chemistry. 6(2). 196–206. 44 indexed citations
4.
Schreuder, Herman, Chantal Tardif, Adolfo Soffientini, et al.. (1997). A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature. 386(6621). 194–200. 187 indexed citations
5.
Akeson, Ann L., Connie W. Woods, Lily C. Hsieh, et al.. (1996). AF12198, a Novel Low Molecular Weight Antagonist, Selectively Binds the Human Type I Interleukin (IL)-1 Receptor and Blocks in Vivo Responses to IL-1. Journal of Biological Chemistry. 271(48). 30517–30523. 67 indexed citations
6.
Sarubbi, Edoardo, Stephen Yanofsky, Ronald W. Barrett, & Maurizio Denaro. (1996). A Cell-Free, Nonisotopic, High-Throughput Assay for Inhibitors of Type-I Interleukin-1 Receptor. Analytical Biochemistry. 237(1). 70–75. 9 indexed citations
7.
Yanofsky, Stephen, John H. Butler, Jeffrey Jacobs, et al.. (1996). High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries.. Proceedings of the National Academy of Sciences. 93(14). 7381–7386. 89 indexed citations
8.
Whitehorn, Erik A., Emily Tate, Stephen Yanofsky, et al.. (1995). A Generic Method for Expression and Use of “Tagged” Soluble Versions of Cell Surface Receptors. Nature Biotechnology. 13(11). 1215–1219. 36 indexed citations
9.
Schreuder, Herman, Chantal Tardif, Adolfo Soffientini, et al.. (1995). Refined Crystal Structure of the Interleukin-1 Receptor Antagonist. Presence of a Disulfide Link and a cis -Proline. European Journal of Biochemistry. 227(3). 838–847. 53 indexed citations
10.
Schreuder, Herman, Chantal Tardif, Adolfo Soffientini, et al.. (1995). Crystals of soluble interleukin‐1 receptor complexed with its natural antagonist reveal a 1:1 receptor‐ligand complex. FEBS Letters. 373(1). 39–40. 6 indexed citations
11.
Schreuder, Herman, Chantal Tardif, Adolfo Soffientini, et al.. (1995). Refined Crystal Structure of the Interleukin‐1 Receptor Antagonist. European Journal of Biochemistry. 227(3). 838–847. 15 indexed citations
12.
Yanofsky, Stephen & Gérard Zurawski. (1990). Identification of key residues in the amino-terminal third of human interleukin-1 alpha.. Journal of Biological Chemistry. 265(22). 13000–13006. 14 indexed citations
13.
Yanofsky, Stephen, Robert A. Love, Judith A. McClarin, et al.. (1987). Clustering of null mutations in the EcoRI endonuclease. Proteins Structure Function and Bioinformatics. 2(4). 273–282. 34 indexed citations
14.
Backman, Keith, Mary C. Betlach, H W Boyer, & Stephen Yanofsky. (1979). Genetic and Physical Studies on the Replication of ColE1-type Plasmids. Cold Spring Harbor Symposia on Quantitative Biology. 43(0). 69–76. 71 indexed citations
15.
Collins, John, Stephen Yanofsky, & Donald R. Helinski. (1978). Altered DNA-protein relaxation complex in a replication mutant of plasmid ColE1. Molecular and General Genetics MGG. 167(1). 21–28. 19 indexed citations
16.
Ito, Junetsu, Fujio Kawamura, & Stephen Yanofsky. (1976). Analysis of ∅29 and ∅15 genomes by bacterial restriction endonucleases, EcoR1 and HpaI. Virology. 70(1). 37–51. 69 indexed citations
17.
Yanofsky, Stephen, Fujio Kawamura, & Junetsu Ito. (1976). Thermolabile transfecting DNA from temperature-sensitive mutant of phage ϕ29. Nature. 259(5538). 60–63. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026